Acylated-based long-acting insulin analogues: Is"misfolding"the problem?
Diabetes Metab. 2014 Nov 18 ;40(6):483-484. Epub 2014 Nov 18. PMID: 25459321
Commentary letter on Hamasaki H and Yanai H. The switching from insulin glargine to insulin degludec reduced HbA1c, daily insulin doses and anti-insulin antibody in anti-insulin antibody-positive subjects with type 1 diabetes.